Racial and Ethnic Differences in Initiation and Discontinuation of Antiarrhythmic Medications in Management of Atrial Fibrillation

References

• Marrouche NF, Brachmann J, Andresen D, et al. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med. 2018;378(5):417–427. doi:10.1056/NEJMoa1707855
   PubMed Web of Science ®Google Scholar
• Kirchhof P, Camm AJ, Goette A, et al. Early rhythm-control therapy in patients with atrial fibrillation. N Engl J Med. 2020;383(14):1305–1316. doi:10.1056/NEJMoa2019422
   PubMed Web of Science ®Google Scholar
• Kushnir A, Barbhaiya CR, Aizer A, et al. Temporal trends in atrial fibrillation ablation procedures at an academic medical center: 2011–2021. J Cardiovasc Electrophysiol. 2023;34:800–807. doi:10.1111/jce.15839
   PubMed Web of Science ®Google Scholar
• Eberly LA, Garg L, Yang L, et al. Racial/ethnic and socioeconomic disparities in management of incident paroxysmal atrial fibrillation. JAMA Network Open. 2021;4(2):e210247. doi:10.1001/jamanetworkopen.2021.0247
   PubMed Web of Science ®Google Scholar
• Amponsah MK, Benjamin EJ, Magnani JW. Atrial fibrillation and race - A contemporary review. Curr Cardiovasc Risk Rep. 2013;7(5):336–345. doi:10.1007/s12170-013-0327-8
   Google Scholar
• Freeman L, Kee A, Tian M, et al. Retrospective claims analysis of treatment patterns, relapse, utilization, and cost among patients with multiple sclerosis initiating second-line disease-modifying therapy. Drugs Real World Outcomes. 2021;8(4):497–508. doi:10.1007/s40801-021-00251-w
   PubMedGoogle Scholar
• Field ME, Goldstein L, Corriveau K, et al. Same-day discharge after catheter ablation in patients with atrial fibrillation in a large nationwide administrative claims database. J Cardiovasc Electrophysiol. 2021;32(9):2432–2440. doi:10.1111/jce.15193
   PubMed Web of Science ®Google Scholar
• O’Byrne ML, DeCost G, Katcoff H, et al. Resource utilization in the first 2 years following operative correction for tetralogy of Fallot: study using data from the optum’s de-identified clinformatics data mart insurance claims database. J Am Heart Assoc. 2020;9(15):e016581. doi:10.1161/JAHA.120.016581
   PubMed Web of Science ®Google Scholar
• D’Angelo RN, Rahman M, Khanna R, et al. Limited duration of antiarrhythmic drug use for newly diagnosed atrial fibrillation in a nationwide population under age 65. J Cardiovasc Electrophysiol. 2021;32(6):1529–1537. doi:10.1111/jce.15012
   PubMed Web of Science ®Google Scholar
• LaPointe NM A, Dai D, Thomas L, et al. Antiarrhythmic drug use in patients <65 years with atrial fibrillation and without structural heart disease. Am J Cardiol. 2015;115(3):316–322. doi:10.1016/j.amjcard.2014.11.005
   PubMedGoogle Scholar
• Biancari F, Teppo K, Jaakkola J, et al. Income and outcomes of patients with incident atrial fibrillation. J Epidemiol Community Health. 2022;76(8):736–742. doi:10.1136/jech-2022-219190
   PubMed Web of Science ®Google Scholar
• Essien UR, Kornej J, Johnson AE, et al. Social determinants of atrial fibrillation. Nat Rev Cardiol. 2021;18(11):763–773. doi:10.1038/s41569-021-00561-0
   PubMed Web of Science ®Google Scholar
• LaRosa AR, Claxton J, O’Neal WT, et al. Association of household income and adverse outcomes in patients with atrial fibrillation. Heart. 2020;106(21):1679–1685. doi:10.1136/heartjnl-2019-316065
   PubMed Web of Science ®Google Scholar
• Xue X, Xie X, Gunter M, et al. Testing the proportional hazards assumption in case-cohort analysis. BMC Med Res Methodol. 2013;13:88. doi:10.1186/1471-2288-13-88
   PubMed Web of Science ®Google Scholar
• U.S. Census Bureau. QuickFacts. Available from: https://www.census.gov/quickfacts/fact/table/US/PST045222. Accessed February 21, 2024.
   Google Scholar
• National Center for Education Statistics. Median household income, by state. Available from: https://nces.ed.gov/programs/digest/d11/tables/dt11_025.asp. Accessed February 21, 2024.
   Google Scholar
• U.S. Census Bureau. Income and poverty in the United States: 2015. Available from: https://www.census.gov/library/publications/2016/demo/p60-256.html. Accessed February 21, 2024.
   Google Scholar
• Yuan Y, Taneja M, Connor AE. The effects of social and behavioral determinants of health on the relationship between race and health status in U.S. Breast Cancer survivors. J Womens Health. 2019;28(12):1632–1639. doi:10.1089/jwh.2018.7360
   Web of Science ®Google Scholar
• Karlson KB, Popham F, Holm A. Marginal and conditional confounding using logits. Sociol Methods Res. 2023;52(4):1765–1784. doi:10.1177/0049124121995548
   PubMed Web of Science ®Google Scholar
• Bhave PD, Lu X, Girotra S, et al. Race- and sex-related differences in care for patients newly diagnosed with atrial fibrillation. Heart Rhythm. 2015;12(7):1406–1412. doi:10.1016/j.hrthm.2015.03.031
   PubMed Web of Science ®Google Scholar
• Cook NL, Ayanian JZ, Orav EJ, et al. Differences in specialist consultations for cardiovascular disease by race, ethnicity, gender, insurance status, and site of primary care. Circulation. 2009;119(18):2463–2470. doi:10.1161/CIRCULATIONAHA.108.825133
   PubMed Web of Science ®Google Scholar
• Eberly LA, Richterman A, Beckett AG, et al. Identification of racial inequities in access to specialized inpatient heart failure care at an academic medical center. Circ Heart Fail. 2019;12(11):e006214. doi:10.1161/CIRCHEARTFAILURE.119.006214
   PubMed Web of Science ®Google Scholar
• Duke JM, Muhammad LN, Song J, et al. Racial disparity in referral for catheter ablation for atrial fibrillation at a single integrated health system. J Am Heart Assoc. 2022;11(18):e025831. doi:10.1161/JAHA.122.025831
   PubMed Web of Science ®Google Scholar
• Hess PL, Hernandez AF, Bhatt DL, et al. Sex and race/ethnicity differences in implantable cardioverter-defibrillator counseling and use among patients hospitalized with heart failure: findings from the get with the guidelines-heart failure program. Circulation. 2016;134(7):517–526. doi:10.1161/CIRCULATIONAHA.115.021048
   PubMed Web of Science ®Google Scholar
• Thomas KL, Al-Khalidi HR, Silverstein AP, et al. Ablation versus drug therapy for atrial fibrillation in racial and ethnic minorities. J Am Coll Cardiol. 2021;78(2):126–138. doi:10.1016/j.jacc.2021.04.092
   PubMed Web of Science ®Google Scholar
• Gruber M, Iglesias M, Khanna R, et al. Heart failure risk in patients with atrial fibrillation treated with catheter ablation vs antiarrhythmic drugs. Heart Rhythm O2. 2023;4(11):681–691. doi:10.1016/j.hroo.2023.09.009
   PubMedGoogle Scholar
• Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge. Int J Stroke. 2021;16(2):217–221. doi:10.1177/1747493019897870
   PubMed Web of Science ®Google Scholar
• Hindricks G, Potpara T, Dagres N, et al. ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European society of cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373–498. doi:10.1093/eurheartj/ehaa612
   PubMed Web of Science ®Google Scholar
• January CT, Wann LS, Alpert JS, et al. AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation. 2014;130(23):e199–267. doi:10.1161/CIR.0000000000000041
   PubMed Web of Science ®Google Scholar
• Golwala H, Jackson LR 2nd, Simon DN, et al. Racial/ethnic differences in atrial fibrillation symptoms, treatment patterns, and outcomes: insights from outcomes registry for better informed treatment for atrial fibrillation registry. Am Heart J. 2016;174:29–36. doi:10.1016/j.ahj.2015.10.028
   PubMed Web of Science ®Google Scholar
• Whittle J, Conigliaro J, Good CB, et al. Do patient preferences contribute to racial differences in cardiovascular procedure use? J Gen Intern Med. 1997;12(5):267–273. doi:10.1007/s11606-006-5062-0
   PubMed Web of Science ®Google Scholar